John Beltrame

Feb 2, 2024 | jpet.aspetjournals.org | John Beltrame |David Wilson

This issue of The Journal of Pharmacology and Experimental Therapeutics contains a comprehensive paper evaluating a novel therapy for coronary vasomotor disorders (Tawa et al., 2024). There is a desperate need to develop new therapies for these diagnostically elusive disorders that are often difficult to treat. Basic science studies play a fundamental role in identifying these therapies but are challenging to translate into a clinical context.

Sep 29, 2023 | nature.com | John Beltrame |Rosanna Tavella

AbstractSuspected myocardial infarction with non-obstructive coronary arteries (MINOCA) has received increasing attention over the past decade.

Sep 1, 2023 | ecrjournal.com | John Beltrame |Peter Ong |Juan Carlos Kaski |Simran Parmar

Average (ratings) Disclosure:PO is a regional editor and JFB is on the European Cardiology Review editorial board; this did not affect peer review. PO has received funding from Berthold Leibinger Foundation and speaker fees from Abbott Medical, Philipps and Pfizer BMS. FC has received speaker fees from Amgen, Astra Zeneca, Abbott, Menarini, Chiesi and Daiichi Sankyo.

Sep 1, 2023 | ecrjournal.com | Juan Carlos Kaski |Hiroaki Shimokawa |John Beltrame |Peter Ong

This special focus issue on coronary artery spasm is dedicated to the memory of Prof Attilio Maseri, a cardiology giant, who sadly died in 2021 but not without leaving an indelible legacy. Born in Udine, Italy, Prof Maseri trained in cardiology and nuclear medicine. He held fellowship positions at Columbia University and Johns Hopkins University in the US.

Jun 7, 2023 | ecrjournal.com | Peter Ong |Astrid Hubert |Maike Schwidder |John Beltrame

Abstract Coronary spasm (CS), which may occur at the epicardial (focal or diffuse spasm) and/or microvascular (microvascular spasm) level, is a well-established cause of myocardial ischaemia, in particular in patients with anginal chest pain despite unobstructed coronary arteries. The diagnosis of CS can be confirmed during coronary angiography by an additional provocation test with vasoactive substances such as acetylcholine.